GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
JAZZ PHARMA INC (JAZZ) [hlAlert]

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate)
oral solution, Luvox CR (fluvoxamine maleate) extended-release capsules and JZP-6 (sodium oxybate). The other product candidates in clinical development are JZP-8 (intranasal clonazepam), being developed for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens, JZP-4 (sodium and calcium channel antagonist), being developed for the treatment of epilepsy and bipolar disorder, and JZP-7 (ropinirole gel), being developed for the treatment of restless legs syndrome.
.
( Total: 23 Current Stock Recommendations )
JAZZ PHARMA INC   (23)
Hold 30% Buy 70%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Hold JAZZ
JAZZ PHARMA INC (JAZZ) rated Mkt Perform by Bernstein
Thursday,  Nov 26, 2015  8:25 AM ET

Rating:
Hold JAZZ
JAZZ PHARMA INC (JAZZ) rated Mkt Perform by Bernstein
Wednesday,  Nov 25, 2015  10:25 AM ET

Rating:
Hold JAZZ
up 174.69 %

Rating:
Buy JAZZ
down 0.76 %

Rating:
Buy JAZZ
up 0.22 %

Rating:
Buy JAZZ
up 25.42 %

Rating:
Buy JAZZ
up 116.96 %

Rating:
Buy JAZZ
up 228.15 %

Rating:
Buy JAZZ
up 147.45 %
JAZZ PHARMA INC (JAZZ) rated Buy with price target $195 by Stifel
Wednesday,  Feb 26, 2014  8:25 AM ET

Rating:
Buy JAZZ
up 5.37 %

Rating:
Buy JAZZ
up 189.19 %
JAZZ PHARMA INC (JAZZ) rated Buy with price target $164 by UBS
Tuesday,  Jan 14, 2014  11:25 AM ET

Rating:
Hold JAZZ

Rating:
Hold JAZZ
up 22.46 %
JAZZ PHARMA INC (JAZZ) downgraded to Neutral by Goldman
Monday,  Dec 16, 2013  8:25 AM ET

Rating:
Buy JAZZ
up 189.19 %
JAZZ PHARMA INC (JAZZ) rated Buy with price target $130 by UBS
Friday,  Dec 6, 2013  12:25 PM ET

Rating:
Buy JAZZ
up 116.96 %

Your Recent Stocks
SymbolLastChange
JAZZ 150.45 down  -11.89 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy